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Abstract
On January 19, 2012, after 131 years of operation, the Eastman Kodak Company filed for Chapter 11
protection in U.S. bankruptcy court. No doubt some people were surprised by this filing, because they grew
up at a time when bright yellow boxes of film accompanied every family vacation and celebration. Those who
were paying more attention offered many explanations for the bankruptcy. Central among them was that
Kodak was late to recognize that it was not in the film and camera business: it was in the imaging business.
With the advent of digital imaging, Kodak was outpaced by other companies that could better achieve
consumer goals.
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What Business Are We In?
On January 19, 2012, after 131 years of operation, the 
Eastman Kodak Company filed 
for Chapter 11 protection in U.S. 
bankruptcy court. No doubt some 
people were surprised by this fil-
ing, because they grew up at a 
time when bright yellow boxes of 
film accompanied every family 
vacation and celebration. Those 
who were paying more attention 
offered many explanations for the 
bankruptcy. Central among them 
was that Kodak was late to rec-
ognize that it was not in the film 
and camera business: it was in 
the imaging business. With the 
advent of digital imaging, Kodak 
was outpaced by other companies 
that could better achieve con-
sumer goals.
This lesson has been repeated 
many times over. In 1960, the edi-
tor of the Harvard Business Review, 
Theodore Levitt, wrote that the 
failure of railroads could be ex-
plained in part by the myopic 
view that they were in the rail-
road business and not the trans-
portation business, which left 
them vulnerable to competition 
from cars, trucks, and planes.1 
Levitt argued that it’s always bet-
ter to define a business by what 
consumers want than by what a 
company can produce. Kodak had 
built a successful enterprise pro-
ducing cameras, film, and photo-
graphic paper and chemicals, but 
what people wanted was images, 
and so when a better way to get 
those images was found, its cus-
tomers followed.
The analogous situation in 
health care is that whereas doc-
tors and hospitals focus on pro-
ducing health care, what people 
really want is health. Health care 
is just a means to that end — 
and an increasingly expensive one. 
If we could get better health some 
other way, just as we can now 
produce images without film and 
transport people and freight with-
out railroads, then maybe we 
wouldn’t have to rely so much on 
health care.
To some of us, the point may 
seem both obvious and irrelevant. 
We might concede that even if 
people don’t intrinsically desire 
doctors’ visits, medications, sur-
gery, and imaging, those services 
are still the way to get people the 
health they want. Although that 
may be true, the leaders of Kodak 
or the railroads may have had 
similar thoughts in their own day. 
Yet they seem to have missed 
some signals. What signals might 
we be missing?
One signal is that while much 
of recent U.S. medical practice 
proceeds as if health and disease 
were entirely biologic, our under-
standing of health’s social deter-
minants has become deeper and 
more convincing. An enormous 
body of literature supports the 
view that differences in health 
are determined as much by the 
social circumstances that under-
lie them as by the biologic pro-
cesses that mediate them. Exam-
ples include the Whitehall study 
of British civil servants that re-
vealed that civil-service grade is 
more strongly associated with 
mortality than any broad biomed-
ical measure2; research conducted 
in the Veterans Affairs health care 
system and elsewhere demonstrat-
ing the persistence of health dis-
parities even within fixed health 
insurance and delivery systems; 
and models of fundamental causes 
that provide a conceptual expla-
nation of how such disparities 
can persist over time, following 
different pathways in changing 
circumstances.3
None of this evidence suggests 
that health care is not an impor-
tant determinant of health or that 
it’s not among the most easily 
modifiable determinants. After all, 
we have established systems to 
support the writing of prescrip-
tions and the performance of sur-
gery or imaging but have found 
no easy way to cure poverty or 
relieve racial residential segrega-
tion. But the evidence does sug-
gest that health care as conven-
tionally delivered explains only a 
small amount — perhaps 10% — 
of premature deaths as compared 
with other factors, including so-
cial context, environmental in-
fluences, and personal behavior.4 
If health care is only a small part 
of what determines health, per-
haps organizations in the busi-
ness of delivering health need to 
expand their offerings.
A second signal is that where-
as in the past there was some 
implicit presumption that doctors 
and hospitals provide health care 
of consistently high quality, that 
presumption is now being chal-
lenged, and we’re getting much 
better at identifying, measuring, 
reporting, and targeting health 
outcomes. For decades, health 
plans, states, and the federal gov-
ernment have been publishing 
quality data at the levels of con-
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ditions, populations, physicians, 
and hospitals. Some of these 
data reflect processes — for ex-
ample, which hospitals are better 
at giving aspirin to patients with 
acute myocardial infarction — 
but more and more data reflect 
outcomes, not just for patients 
within hospitals but for the pop-
ulations surrounding them. The 
Mobilizing Action toward Com-
munity Health project has been 
publishing ratings of county-level 
population health. Employers in-
creasingly focus on employee well-
ness, on one side, and disease 
management, on the other. Re-
search funding increasingly sup-
ports efforts to improve these 
measures and effectively commu-
nicate outcomes. Each of these 
approaches has advanced incre-
mentally over decades. This trend 
reveals an interest in what ulti-
mately happens to individuals and 
populations.
A third signal is that health 
care financing is testing these 
pathways too. Payment systems 
that will not reimburse prevent-
able readmissions or that bundle 
payments for goals or episodes 
of care rather than visits reflect a 
population approach to health fo-
cused on outcomes rather than 
processes. Today’s standard ap-
proach of reimbursing for office 
visits and hospitalizations is likely 
to be displaced once better mea-
sures of outcomes can provide a 
substitute that’s more relevant to 
our key goals. If we can measure 
success, why pay for process? If 
we can get the images we want in 
a better way, why use photograph-
ic film, paper, and chemicals?
In the future, successful doc-
tors, hospitals, and health systems 
will shift their activities from de-
livering health services within 
their walls toward a broader range 
of approaches that deliver health. 
Although we’re seeing the earli-
est steps in this shift toward ac-
countability for health, we current-
ly lack both good tools for moving 
forward in any substantial way 
and more established pathways for 
redirecting financing toward those 
outcomes.5 What do we need to 
move from a product-oriented in-
dustry to a customer-oriented one?
Surely, Kodak’s employees and 
shareholders lost something as 
their company lost business to oth-
er firms. But the world is at least 
narrowly better thanks to the ways 
photographs are now produced. 
Doctors and hospitals who pay 
attention to the business they are 
actually in — defined by the out-
comes their “customers” seek — 
will leave the doctors and hospi-
tals who don’t behind, captured 
in a Kodak moment.
Disclosure forms provided by the au-
thors are available with the full text of this 
article at NEJM.org.
From the Center for Health Equity Research 
and Promotion, Philadelphia Veterans Af-
fairs Medical Center; the Penn Medicine 
Center for Innovation; and the Wharton 
School, University of Pennsylvania — all in 
Philadelphia. 
This article was published on August 29, 
2012, at NEJM.org.
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What Business Are We In?
From Sick Care to Health Care — Reengineering Prevention 
into the U.S. System
Farshad Fani Marvasti, M.D., M.P.H., and Randall S. Stafford, M.D., Ph.D.
Although the United States pays more for medical care 
than any other country, problems 
abound in our health care sys-
tem. Unsustainable costs, poor 
outcomes, frequent medical er-
rors, poor patient satisfaction, 
and worsening health disparities 
all point to a need for transfor-
mative change.1 Simultaneously, 
we face widening epidemics of 
obesity and chronic disease. Car-
diovascular disease, cancer, and 
diabetes now cause 70% of U.S. 
deaths and account for nearly 
75% of health care expenditures.2 
Unfortunately, many modifiable 
risk factors for chronic diseases 
are not being addressed adequate-
ly. A prevention model, focused 
on forestalling the development 
of disease before symptoms or 
life-threatening events occur, is 
the best solution to the current 
crisis.
Disease prevention encompass-
es all efforts to anticipate the 
genesis of disease and forestall 
its progression to clinical mani-
festations. A focus on prevention 
does not imply that disease can 
be eliminated but instead em-
braces Fries’s model of “morbid-
The New England Journal of Medicine 
Downloaded from nejm.org on August 16, 2017. For personal use only. No other uses without permission. 
 Copyright © 2012 Massachusetts Medical Society. All rights reserved. 
